App-Quantinova.ai

Routine Assessment of Patient Index Data 3 (RAPID3)-Defined Remission Is As Stringent As ACR/EULAR Boolean-Defined Remission in a Clinical Trial of Patients with Early Rheumatoid Arthritis Treated with Abatacept

Yusuf Yazici - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Abatacept

Clinical Variables Associated with Thrombosis At Systemic Lupus Erythematosus Diagnosis. Differences Between Patients with Positive/Negative Lupus Anticoagulant

Andrea Hinojosa-Azaola - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Diagnostic Value of High Sensitivity C Reactive Protein for Early Axial Spondyloarthritis: Results From the Devenir Des Spondylarthopathies Indifferenciees Recentes Cohort

Victoria Navarro-Compan - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Fetuin A: A New Biomarker Related with Syndesmophytes in Patients with Ankylosing Spondylitis

Tugba Tuylu - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

N/A

High Sensitivity C-Reactive Protein, Disease Activity and Cardiovascular Risk Factors in Systemic Lupus Erythematosus

Chi Chiu Mok - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Sarilumab, a Subcutaneously-Administered, Fully-Human Monoclonal Antibody Inhibitor of the IL-6 Receptor: Effects On Hemoglobin Levels in a Clinical Trial for the Treatment of Moderate-to-Severe Rheumatoid Arthritis

Mark C. Genovese - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Sarilumab

Sarilumab, a Subcutaneously-Administered, Fully-Human Monoclonal Antibody Inhibitor of the IL-6 Receptor: Pharmacokinetic Profile and Its Relationship to Changes in Pharmacodynamic Markers in Patients with Rheumatoid Arthritis

Pavel Belomestnov - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Select Soluble Inflammatory Mediators Are Detected Prior to and Increase At Systemic Lupus Erythematosus Classification

Melissa E. Munroe - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Interferon

The Association of Serum Biomarkers and Metabolic Syndrome with Subclinical Atherosclerosis in Systemic Lupus Erythematosus: A Controlled Analysis in Patients with No Clinical Disease Activity

Semra Ertan-Demir - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Interleukin

Two Novel Diagnostic Biomarkers of Cartilage Degradation and Connective Tissue Inflammation Are Predictive of Disease Progression in Ankylosing Spondylitis

Anne C. Bay-Jensen - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

N/A

Vitamin D Deficiency Is Associated with, but Does Not Predict, Change in hsCRP in Systemic Lupus Erythematosus (SLE)

Adnan Kiani - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Ergocalciferol

Anti-TNF Therapy Induces Positive Changes In The Lipoprotein Profile Of RA Patientes. Results Of a Prospective Study

Jaime Calvo-Alen - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Chondrocyte Hypertrophy, Measured By The Secretion Of Collagen Type X, Is Associated With Cartilage Degradation and Systemic Inflammation In Osteoarthritis

Yi He - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Systemic inflammation

N/A

Cognitive Dysfunction, a Non-Inflammatory Neuropsychiatric Syndrome In Systemic Lypus Erythematosus

Juanita Romero-Diaz - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Cognitive dysfunction

N/A

Correlation of Carotid Intima Media Thickness With Interleukin-6, Tumor Necrosis Factor-? and Anti-Cyclic Citrullinated Peptides In Rheumatoid Arthritis

Lourdes Nunez Atahualpa - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

ILS-969

CXCL13 Is Elevated In Early and In Established Seropositive Rheumatoid Arthritis and Correlates With Rheumatoid Factor Levels

Jonathan D. Jones - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Effect Of Biologic Agents On Lipids and Cardiovascular Risk In Rheumatoid Arthritis Patients

Dimitrios A. Pappas - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Tocilizumab

Hypovitaminosis D and The Metabolic Syndrome In Patients With Systemic Lupus Erythematosus (SLE)

Chi Chiu Mok - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Identification Of Osteoarthritis Patients With Chronic Inflammation Driven Disease Progression

Anne Sofie Siebuhr - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Osteoarthritis

N/A

Reversing Vascular Dysfunction In Rheumatoid Arthritis: Peroxisome Proliferator-Activated Receptor Gamma Agonist Therapy Improves Augmentation Index But Not Endothelial Function

Michelle J. Ormseth - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Pioglitazone

Filters

1408 Abstracts